Carlos Luis Lopez
CIK: 0002042509
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Niagen Bioscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 30, 2026NAGE
Niagen Bioscience, Inc.
Award(A)Direct2.3K shares at avg. $2.71$6K - Feb 19, 2026NAGE
Niagen Bioscience, Inc.
Award(A)DirectEmployee Stock Options (right to buy)
41.4K shares- - Mar 7, 2025CDXC
ChromaDex Corp.
Purchase(P)Direct273 shares at avg. $7.86$2K - Feb 12, 2025CDXC
ChromaDex Corp.
Award(A)DirectEmployee Stock Options (right to buy)
19.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | NAGE Niagen Bioscience, Inc. | Award(A) | 2,314 | $2.71 | $6,271 | Direct |
| Feb 19, 2026 | NAGE Niagen Bioscience, Inc. | Award(A) Employee Stock Options (right to buy) | 41,420 | - | - | Direct |
| Mar 7, 2025 |  CDXC ChromaDex Corp. | Purchase(P) | 273 | $7.86 | $2,146 | Direct |
| Feb 12, 2025 | CDXC ChromaDex Corp. | Award(A) Employee Stock Options (right to buy) | 19,691 | - | - | Direct |
1-4 of 4 transactions
About Lopez Carlos Luis
Lopez Carlos Luis (SEC CIK 0002042509) files insider reports with the SEC as SVP, General Counsel of Niagen Bioscience, Inc. (NAGE).
Signal8 holds 5 ownership filings by Lopez Carlos Luis (1 Form 3, 4 Form 4), filed between Nov 8, 2024 and Jul 8, 2026. Those filings report 4 transactions, from Feb 12, 2025 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lopez Carlos Luis's filings is in LOS ANGELES, CA.
Recent filings by Lopez Carlos Luis
Other insiders filing for Niagen Bioscience, Inc. (NAGE)
- Pamir Ozan, Chief Financial Officer
- Fried Robert N, Chief Executive Officer
- YU Wing Tak Wendy, Director
- Ng Wang Yu Gary, Director
- Cohen Ann, Director
- Patrick Kristin, Director